Inhibitors | Comment | Organism | Structure |
---|---|---|---|
sitagliptin | in a 24-week study, once-daily sitagliptin monotherapy improves glycemic control in the fasting and postprandial states, improves measures of beta-cell function, and is well tolerated in patients with type 2 diabetes | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
patients with type 2 diabetes | - |
Synonyms | Comment | Organism |
---|---|---|
dipeptidyl peptidase-4 | - |
Homo sapiens |